David Ian Johnson
CIK 1563432 · Executive Chairman · last filed 2024-10-24
David Ian Johnson is an Executive Chairman who has filed 24 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for AIFF, was dated Oct 24, 2024. Across all open-market trades the lifetime net is +$171.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $848.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$848.0K
3
24
$171.7K
Holdings By Company
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-24 | AIFF | Grant (A) | +557,885 | $0 | EDGAR |
| 2021-02-17 | ENVB | Grant (A) | — | $0 | EDGAR |
| 2017-06-29 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | +300,000 | $0 | EDGAR |
| 2017-06-26 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | +500,000 | $0 | EDGAR |
| 2017-04-04 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +250,000 | $100.0K | EDGAR |
| 2016-05-13 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | +300,000 | $0 | EDGAR |
| 2016-02-11 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | +59,932 | $0 | EDGAR |
| 2015-11-09 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +8,650 | $25.3K | EDGAR |
| 2015-07-06 | Alliqua BioMedical, Inc. (ALQA) Delisted | Tax (F) | −19,191 | -$102.7K | EDGAR |
| 2015-05-28 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +10,000 | $46.5K | EDGAR |